Board of Pharmacy Approves Changes to Regulatory Language for Pharmacists Furnishing Opioid Antagonists

By Shannon Dart At its February 6–7, 2023 meeting (at 10:11:15), the Board of Pharmacy approved the recommendations from the Licensing Committee to move forward with changing regulatory language related to the authority of a licensed pharmacist to furnish opioid Continue reading

Court of Appeal Sides with Medical Board of California and other State Agencies in Opioid Litigation Discovery Dispute

By Jonathan Padua On January 15, 2021, in Board of Registered Nursing v. The Superior Court of Orange County (Johnson & Johnson), 59 Cal. App. 5th 1011 (2021), the Fourth District Court of Appeal issued a peremptory writ of mandate Continue reading

Court of Appeal Grants Protective Order in Favor of the Board of Registered Nursing and Upholds Patient Privacy Rights

By Kendra J. Muller Board of Registered Nursing v. Johnson & Johnson et al., Case No. 30-2014-00725287 (Super. Ct., Orange County). On May 21, 2014, in The People of the State of California v. Purdue Pharma, L.P., et al., the Continue reading